Abbonarsi

New-generation full-spectrum endoscopy versus standard forward-viewing colonoscopy: a multicenter, randomized, tandem colonoscopy trial (J-FUSE Study) - 10/10/18

Doi : 10.1016/j.gie.2018.06.011 
Toyoki Kudo, MD, PhD 1, , Yutaka Saito, MD, PhD 2, Hiroaki Ikematsu, MD, PhD 3, Kinichi Hotta, MD 4, Yoji Takeuchi, MD 5, Masaaki Shimatani, MD, PhD 6, Ken Kawakami, MD, PhD 7, Naoto Tamai, MD, PhD 8, Yuichi Mori, MD, PhD 1, Yasuharu Maeda, MD, PhD 1, Masayoshi Yamada, MD, PhD 2, Taku Sakamoto, MD 2, Takahisa Matsuda, MD, PhD 2, Kenichiro Imai, MD 4, Sayo Ito, MD 4, Kenta Hamada, MD 5, Norimasa Fukata, MD, PhD 6, Takuya Inoue, MD, PhD 7, Hisao Tajiri, MD, PhD 9, Kenichi Yoshimura, PhD 10, Hideki Ishikawa, MD, PhD 11, Shin-ei Kudo, MD, PhD 1
1 Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan 
2 Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan 
3 Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Chiba, Japan 
4 Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan 
5 Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan 
6 Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan 
7 Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan 
8 Department of Endoscopy, Jikei University School of Medicine, Tokyo, Japan 
9 Department of Innovative Interventional Endoscopy Research, Jikei University School of Medicine, Tokyo, Japan 
10 Innovative Clinical Research Center, Kanazawa University Hospital, Kanazawa, Japan 
11 Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan 

Reprint requests: Toyoki Kudo, MD, PhD, Digestive Disease Centre, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-chuo, Tsuzuki-ku, Yokohama 224-8503, Japan.Digestive Disease CentreShowa University Northern Yokohama Hospital35-1 Chigasaki-chuoTsuzuki-kuYokohama224-8503Japan

Abstract

Background and Aims

Although colonoscopy is the criterion standard for detection of colorectal adenomas, some adenomas are missed. Full-spectrum endoscopy (FUSE) allows for observation with a 330-degree angle of view, which is expected to decrease the miss rate. However, no consensus has been reached regarding the superiority of FUSE over standard forward-viewing colonoscopy (SFVC) for detection of adenomas; we therefore compared new-generation FUSE and SFVC regarding colorectal adenoma miss rate (AMR) in this, the first reported randomized control trial using new-generation FUSE.

Methods

We enrolled individuals aged 40 to 75 years who had been referred for screening, surveillance, fecal occult blood test positivity, or symptoms in a prospective randomized trial of tandem colonoscopy in 8 institutions. Patients were randomly assigned (1:1) via computer-generated stratified randomization. Neither the endoscopists nor patients were blinded to the allocation. The primary endpoint was AMR per patient (AMR-PP).

Results

We enrolled 345 patients and included 319 in the per-protocol analyses. AMR-PP was significantly lower with FUSE (11.7%; 95% confidence interval [CI], 8.0%-15.4%) than with SFVC (22.9%; 95% CI, 17.5%-28.3%; P < .001). AMR-PP for lesions ≤5 mm in size was significantly lower with FUSE (10.4%; 95% CI, 6.5%-14.3%) than with SFVC (20.0%; 95% CI, 14.4%-25.6%; P = .0057). Furthermore, AMR-PP in the ascending colon was significantly lower with FUSE (4.3%; 95% CI, 1.4%-7.2%) than with SFVC (10.6%; 95% CI, 6.1%-15.1%; P = .0212).

Conclusions

FUSE is superior to SFVC regarding both AMR-PP and AMR; additionally, AMR-PP is both significantly lower with FUSE than SFVC for lesions ≤5 mm in size and in the ascending colon. (Clinical trial registration number: UMIN000020448.)

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ADR, AMR, AMR-PP, CRC, EU, FUSE, PMR, PMR-PP, SCIR, SFVC


Mappa


 DISCLOSURE: The following author disclosed financial relationships relevant to this publication: S. Kudo: Consultant for and study funding from Adachi Corporation. All other authors disclosed no financial relationships relevant to this publication. Research support for this study was provided by Adachi, Osaka, Japan.
 See CME section, p. 868.
 If you would like to chat with an author of this article, you may contact Dr Kudo at s6027@nms.ac.jp.


© 2018  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 88 - N° 5

P. 854-864 - novembre 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Long-term recurrent bleeding risk after endoscopic therapy for definitive colonic diverticular bleeding: band ligation versus clipping
  • Naoyoshi Nagata, Naoki Ishii, Mitsuru Kaise, Takuro Shimbo, Toshiyuki Sakurai, Junichi Akiyama, Naomi Uemura
| Articolo seguente Articolo seguente
  • The FUSE enigma: Wide-angle or wide-minded?
  • Cesare Hassan, Alessando Repici

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.